Busulfan is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Busulfan.
Product ID | 60505-6177_57135d3b-4450-8bd3-8e18-bd09dda34358 |
NDC | 60505-6177 |
Product Type | Human Prescription Drug |
Proprietary Name | Busulfan |
Generic Name | Busulfan |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-08-19 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA210448 |
Labeler Name | Apotex Corp. |
Substance Name | BUSULFAN |
Active Ingredient Strength | 6 mg/mL |
Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-08-19 |
Marketing End Date | 2023-01-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA210448 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-08-19 |
Marketing Category | ANDA |
Application Number | ANDA210448 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-08-19 |
Ingredient | Strength |
---|---|
BUSULFAN | 6 mg/mL |
SPL SET ID: | a67d61d4-f985-e653-5343-b49d17784b3c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-1112 | BUSULFAN | BUSULFAN |
16729-351 | Busulfan | busulfan |
25021-241 | Busulfan | Busulfan |
45963-640 | Busulfan | Busulfan |
51817-170 | Busulfan | busulfan |
60505-6177 | Busulfan | busulfan |
65219-160 | Busulfan | Busulfan |
67457-893 | Busulfan | Busulfan |
70121-1244 | Busulfan | Busulfan |
70860-216 | Busulfan | busulfan |
71288-116 | Busulfan | Busulfan |
71288-158 | Busulfan | Busulfan |
72485-210 | Busulfan | Busulfan |
72606-559 | Busulfan | Busulfan |
59148-047 | BUSULFEX | busulfan |
59148-070 | BUSULFEX | busulfan |
69784-620 | MYLERAN | busulfan |
76388-713 | MYLERAN | busulfan |
0517-0920 | N/A | busulfan |